Functional gastrointestinal disorders induced by esophageal atresia surgery: is it valid in humans?

Ugur Halac1, Marine Revillion, Laurent Michaud

  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Sainte-Justine Hospital, Université de Montréal, Montréal, Québec, Canada.

Insights

Neonatal stress from esophageal atresia (EA) repair does not significantly increase the risk of functional gastrointestinal disorders (FGID) in children. This study found no evidence linking EA to later FGID development.

Area of Science:

  • Pediatric Gastroenterology
  • Developmental Biology
  • Surgical Outcomes

Background:

  • Functional gastrointestinal disorders (FGID) affect a significant portion of the pediatric population.
  • Neonatal stressors, such as maternal separation, are implicated in FGID development.
  • Congenital esophageal atresia (EA) involves significant neonatal stress due to surgical correction.

Purpose of the Study:

  • To investigate if congenital esophageal atresia (EA) is a significant risk factor for developing FGID later in life.
  • To compare the incidence of FGID in children with EA to healthy controls.
  • To determine if neonatal stress from EA repair impacts FGID development.

Main Methods:

  • A multicenter cohort study comparing children with EA to age- and sex-matched healthy controls.
  • Assessment of gastrointestinal symptoms using questionnaires.
  • Diagnosis of FGID based on the Rome III criteria.

Main Results:

  • No significant difference in FGID diagnosis rates between children with EA (21%) and controls (11%).
  • Associated malformations, early complications, or prolonged hospital stays in EA patients did not affect FGID incidence.
  • Chronic abdominal pain was reported by 38% of EA subjects versus 25% of controls, a non-significant difference.

Conclusions:

  • Neonatal stress from surgical correction of EA is not a clinically significant risk factor for childhood FGID.
  • The study did not find a strong association between EA and the development of FGID.
  • Further research may explore other contributing factors to FGID in this population.
Abstract

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...